{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:36:05Z","timestamp":1770752165951,"version":"3.50.0"},"reference-count":28,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007479","name":"Fondazione Cassa di Risparmio di Padova e Rovigo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare the results from an initial negative human papillomavirus (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>) test with re\u2010screening after 3 years in women attending two <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>\u2010based screening programmes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Population\u2010based cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Two cervical service screening programmes in Italy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Population<\/jats:title><jats:p>Women aged 25\u201364 years invited to screening from April 2009 to October 2015.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eligible women were invited to undergo an <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> test. Those with a negative <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> test went on to the next screening round 3 years later. Cytology triage was performed for <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>+ (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> by Hybrid Capture 2) samples, with immediate colposcopy (if abnormal) and <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> re\u2010testing 1 year later (if negative).<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Participation rate, positivity at <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> and at triage, referral rate to colposcopy, positive predictive value for cervical intraepithelial neoplasia grade 2+ (<jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+) at colposcopy, and detection rate for <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We present the results from 48 751 women at the first screening and 22 000 women at re\u2010screening 3 years later. The response rate was slightly higher at the second screening (74.5 versus 72.1% at the first screening; referral rate, <jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> 1.11; 95% confidence interval, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 1.07\u20131.14). Compared with the first screening, we observed a significant reduction at the second screening in terms of <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> positivity (<jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> 0.55, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.51\u20130.60), referral rate to colposcopy (<jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> 0.47, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.41\u20130.53), <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+ detection rate (<jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> 0.24, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.13\u20130.39), and positive predictive value (<jats:styled-content style=\"fixed-case\">PPV<\/jats:styled-content>) for <jats:styled-content style=\"fixed-case\">CIN<\/jats:styled-content>2+ at colposcopy (<jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> 0.51, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.29\u20130.87).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The very low frequency of disease and inadequate <jats:styled-content style=\"fixed-case\">PPV<\/jats:styled-content> at colposcopy indicate that a 3\u2010year interval after a negative <jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content> test is too short.<\/jats:p><\/jats:sec><jats:sec><jats:title>Tweetable abstract<\/jats:title><jats:p>Three years after a negative HPV the frequency of cervical disease is so low that re\u2010screening is inefficient.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1471-0528.14575","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T23:33:13Z","timestamp":1485300793000},"page":"1585-1593","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A 3\u2010year interval is too short for re\u2010screening women testing negative for human papillomavirus: a population\u2010based cohort study"],"prefix":"10.1111","volume":"124","author":[{"given":"M","family":"Zorzi","sequence":"first","affiliation":[{"name":"Veneto Tumour Registry Veneto Region Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Frayle","sequence":"additional","affiliation":[{"name":"Immunologia Diagnostica Molecolare Oncologica Istituto Oncologico Veneto IOV\u2010IRCCS Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rizzi","sequence":"additional","affiliation":[{"name":"Immunologia Diagnostica Molecolare Oncologica Istituto Oncologico Veneto IOV\u2010IRCCS Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Fedato","sequence":"additional","affiliation":[{"name":"Organizational Unit Prevention and Public Health Veneto Region Venezia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Rugge","sequence":"additional","affiliation":[{"name":"Veneto Tumour Registry Veneto Region Padova Italy"},{"name":"Department of Medicine DIMED Pathology and Cytopathology Unit University of Padova Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MG","family":"Penon","sequence":"additional","affiliation":[{"name":"Department of Prevention Local Health Unit 17 Monselice Este Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Bertazzo","sequence":"additional","affiliation":[{"name":"Department of Prevention Local Health Unit 17 Monselice Este Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Callegaro","sequence":"additional","affiliation":[{"name":"Department of Prevention Local Health Unit 15 Alta Padovana Camposampiero Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Campagnolo","sequence":"additional","affiliation":[{"name":"Department of Prevention Local Health Unit 15 Alta Padovana Camposampiero Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Ortu","sequence":"additional","affiliation":[{"name":"Department of Prevention Local Health Unit 15 Alta Padovana Camposampiero Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Del Mistro","sequence":"additional","affiliation":[{"name":"Immunologia Diagnostica Molecolare Oncologica Istituto Oncologico Veneto IOV\u2010IRCCS Padova Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the Veneto HPV\u2010screening Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.095"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1754"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju153"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62218-7"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.11.076"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.121505"},{"key":"e_1_2_6_8_1","volume-title":"Population screening for cervical cancer","author":"Health Council of the Netherlands","year":"2011"},{"key":"e_1_2_6_9_1","unstructured":"Ministero della Salute. Piano Nazionale della prevenzione 2010\u20102012.Azione centrale prioritaria concernente la \u201cDefinizione di documenti tecnici di sintesi delle evidenze scientifiche\u201d a supporto della programmazione monitoraggio e valutazione degli interventi di prevenzione oncologica nella popolazione a rischio. Ministero della Salute DGPRE 001068\u2010P\u201014\/01\/2013 pagg. 1\u201022. [http:\/\/www.osservatorionazionalescreening.it\/sites\/default\/files\/allegati\/Screening.pdf] Accessed 4 August 2015."},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-12-201206190-00424"},{"key":"e_1_2_6_11_1","first-page":"S1","article-title":"Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors","volume":"36","author":"Ronco G","year":"2012","journal-title":"Epidemiol Prev"},{"key":"e_1_2_6_12_1","first-page":"1","volume-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening","author":"Ronco G","year":"2015"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21139"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.12.022"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0969141314522219"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12272"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp471"},{"issue":"4","key":"e_1_2_6_18_1","first-page":"S1","article-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer program","volume":"29","author":"Coleman D","year":"1993","journal-title":"Eur J Cancer"},{"key":"e_1_2_6_19_1","first-page":"19","volume-title":"Raccomandazioni sul test HR\u2010HPV come test di screening primario e rivisitazione del ruolo del Pap test","author":"Gruppo Italiano Screening Citologico (GISCi)","year":"2010"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.2007.00469.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/657321"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0969141314561707"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61450-0"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj209"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70731-8"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70156-1"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073204"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70360-2"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29381"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1471-0528.14575","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.14575","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T13:18:21Z","timestamp":1695475101000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/1471-0528.14575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1111\/1471-0528.14575"],"URL":"https:\/\/doi.org\/10.1111\/1471-0528.14575","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]},"assertion":[{"value":"2016-12-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}